(−)-Syringaresinol suppressed LPS-induced microglia activation via downregulation of NF-κB p65 signaling and interaction with ERβ
- 1 October 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 99, 107986
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission (18JCQNJC13400, 19JCZDJC36200, 81971858)
- National Natural Science Foundation of China (18JCQNJC13400, 19JCZDJC36200, 81971858)
- Tianjin Municipal Natural Science Foundation (18JCQNJC13400, 19JCZDJC36200, 81971858)
This publication has 45 references indexed in Scilit:
- Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthaseExperimental & Molecular Medicine, 2012
- Blocking NF-κB: An Inflammatory IssueProceedings of the American Thoracic Society, 2011
- Individual differences in chronically defeated male mice: Behavioral, endocrine, immune, and neurotrophic changes as markers of vulnerability to the effects of stressStress, 2011
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Anti-angiogenic activity of julibroside J8, a natural product isolated from Albizia julibrissinPhytomedicine, 2009
- (–)-Syringaresinol inhibits proliferation of human promyelocytic HL-60 leukemia cells via G1 arrest and apoptosisInternational Immunopharmacology, 2008
- Debris clearance by microglia: an essential link between degeneration and regenerationBrain, 2008
- Immunity by ubiquitylation: a reversible process of modificationNature Reviews Immunology, 2005
- A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma CellsJournal of Biological Chemistry, 2002
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994